Aortic Stenosis and Renal Function: A Bidirectional Mendelian Randomization Analysis
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.034102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Jonathan L Ciofani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health The University of Sydney Sydney NSW Australia. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Renal Insufficiency, Chronic, Glomerular Filtration Rate, Genome-Wide Association Study. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Large observational studies have demonstrated a clear inverse association between renal function and risk of aortic stenosis (AS). Whether this represents a causal, reverse causal or correlative relationship remains unclear. We investigated this using a bidirectional 2‐sample Mendelian randomization approach. Methods and Results We collected summary statistics for the primary analysis of chronic kidney disease (CKD) and AS from genome‐wide association study meta‐analyses including 480 698 and 653 867 participants, respectively. We collected further genome‐wide association study summary statistics from up to 1 004 040 participants for sensitivity analyses involving estimated glomerular filtration rate (eGFR) derived from creatinine, eGFR derived from cystatin C, and serum urea nitrogen. Inverse‐variance weighted was the primary analysis method, with weighted‐median, weighted‐mode, Mendelian randomization‐Egger, and Mendelian randomization‐Pleiotropy Residual Sum and Outlier as sensitivity analyses. We did not find evidence of a causal relationship between genetically predicted CKD liability as the exposure and AS as the outcome (odds ratio [OR], 0.94 per unit increase in log odds of genetic liability to CKD [95% CI, 0.85–1.04], P =0.26) nor robust evidence of AS liability as the exposure and CKD as the outcome (OR, 1.04 per unit increase in log odds of genetic liability to AS [95% CI, 0.97–1.12], P =0.30). The sensitivity analyses were neutral overall, as were the analyses using eGFR derived from creatinine, eGFR derived from cystatin C, and serum urea nitrogen. All positive controls demonstrated strong significant associations.
Conclusions
The present study did not find evidence of a substantial effect of genetically predicted renal impairment on risk of AS. This has important implications for research efforts that attempt to identify prevention and treatment targets for both CKD and AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health The University of Sydney Sydney NSW Australia.
- Department of Cardiology Royal North Shore Hospital Sydney NSW Australia.
- Department of Epidemiology and Biostatistics, School of Public Health Imperial College London London UK.
- Medical Research Council Laboratory of Molecular Biology Cambridge UK.
- Department of Physiology, Development and Neuroscience University of Cambridge Cambridge UK.
- School of Mathematics and Statistics University of New South Wales Sydney NSW Australia.
ORCID-Profile: Jonathan L Ciofani, Daniel Han, Usaid K Allahwala
Zitieren
APA
Ciofani, J. L., Han, D., Allahwala, U. K., & Bhindi, R. (2024). Aortic Stenosis and Renal Function: A Bidirectional Mendelian Randomization Analysis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.034102
Vancouver
Ciofani JL, Han D, Allahwala UK, Bhindi R. Aortic Stenosis and Renal Function: A Bidirectional Mendelian Randomization Analysis. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.034102
BibTeX
@article{Ciofani2024,
author = {Ciofani, Jonathan L and Han, Daniel and Allahwala, Usaid K and Bhindi, Ravinay},
title = {Aortic Stenosis and Renal Function: A Bidirectional Mendelian Randomization Analysis},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.034102}
}
EUVIMED